Navigation Links
AMT's Cooperative Research and Development Agreement With NIH to Boost Production Capacity
Date:5/25/2008

rapies to benefit far larger patient groups than was hitherto thought possible. In addition, it would allow us to attempt the treatment of diseases that require the systemic (as opposed to local) expression of therapeutic genes. Duchenne Muscular Dystrophy is such a disease, and together with La Sapienza in Rome we will work very hard to develop a treatment for this wasting disorder for which there is currently no treatment."

About Amsterdam Molecular Therapeutics

AMT has a unique gene therapy platform that to date appears to circumvent many if not all of the obstacles that have prevented gene therapy from becoming a mainstay of clinical medicine. Using adeno-associated viral (AAV) vectors as the delivery vehicle of choice for therapeutic genes, the company has been able to design and validate what is probably the first stable and scalable AAV production platform. As such, AMT's proprietary platform holds tremendous promise for thousands of rare (orphan) diseases that are caused by one faulty gene. AMT currently has a product pipeline with six products at different stages of development.

Certain statements in this press release are "forward-looking statements" including those that refer to management's plans and expectations for future operations, prospects and financial condition. Words such as "strategy," "expects," "plans," "anticipates," "believes," "will," "continues," "estimates," "intends," "projects," "goals," "targets" and other words of similar meaning are intended to identify such forward-looking statements. Such statements are based on the current expectations of the management of Amsterdam Molecular Therapeutics only. Undue reliance should not be placed on these statements because, by their nature, they are subject to known and unknown risks and can be affected by factors that are beyond the control of AMT. Actual results could differ materially from current expectations due to a number of factors and uncertainties affecting AMT's b
'/>"/>

SOURCE Amsterdam Molecular Therapeutics B.V
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. NASA Extends Cooperative Agreement With NSBRI
2. Kiwa Bio-Tech Products Group Discusses Cooperative Efforts With Canadian Agricultural Ministry and Canadian Company
3. Kiwa Bio-Tech Products Group Discusses Cooperative Research With the University of Waterloo, Canada
4. DMetrix and the Armed Forces Radiobiology Research Institute Announce Cooperative Research and Development Agreement
5. Research Triangle Area Health Care Collaborative Launches Bridges to Excellence(R) Initiative to Improve Quality and Lower Costs
6. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
7. BioMarin Licenses Technology From Leading Cystic Fibrosis Research Laboratory at the University of California, San Francisco
8. IDM Pharma Names Dr. Jeffrey W. Sherman Chief Medical Officer and Senior Vice President of Research and Development
9. Dawson James Securities Initiates Research Coverage on CryoCor, Inc. (Nasdaq: CRYO) with a Strong Buy Rating and $6.00 Target Price
10. eResearchTechnology to Present at the Thomas Weisel Healthcare Conference 2007 on September 5th
11. The Debiopharm Life Sciences Award Goes to Dr Nusser for his Outstanding Research in Neuroscience
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... Basel, Switzerland (PRWEB) September 30, 2014 ... advanced software solutions for drug discovery and ... the FUNGITECT consortium has chosen Genedata Selector ... next-generation sequencing (NGS) data. FUNGITECT is a ... of invasive fungal diseases via individualized anti-fungal ...
(Date:9/30/2014)... Md., Sept. 30, 2014 BioHealth Innovation, ... commercializing market-relevant biohealth innovations and increasing access to early-stage ... today that venture capitalist, Tania Fernandez , Ph.D., ... Dr. Fernandez will be a member of the management ... provide up to $50 million in seed and early-stage ...
(Date:9/30/2014)... Sept. 30, 2014 The overall research ... (NGS) sequencing trends and use. Most researchers outsource ... expected to increase within the next 12 months. ... criteria for purchasing sequencing instruments. Disease-related research is ... of RNA-Seq continues to surge, with half of ...
(Date:9/30/2014)... MA (PRWEB) September 30, 2014 ... (UC) and collaboration company is dedicated to supporting ... connectivity needs. Julie Power, a carrier ... to ensure collaboration solutions stays connected and productive ... to the increased movement of businesses to cloud ...
Breaking Biology Technology:FUNGITECT Consortium Adopts Genedata Selector as Data Analysis Platform for Anti-fungal R 2FUNGITECT Consortium Adopts Genedata Selector as Data Analysis Platform for Anti-fungal R 3Seasoned Life Sciences Venture Capitalist Tania Fernandez Joins BHI to Help Manage New BioHealth Gap Fund 2Global Next-generation Sequencing Trends 2SoundConnect Expands Carrier Services Division 2
... , , SAN CARLOS, Calif., Sept. 21 ... hosting a conference call to discuss today,s announcement of a new partnership for ... (ET)/5:30 a.m. Pacific Time (PT). , , The live audio-only ... posted on the home page of Nektar,s website: http://www.nektar.com . ...
... ... solution to inventory Ultra-low Freezer and Liquid Nitrogen Tank samples and efficiently manage data ... ... Inc. today announced the release of FreezerPro 2010, Frozen sample inventory and information management ...
... the business of developing high-speed electronic components, it pays ... track of them you will need to use dedicated ... UltraFast Innovations GmbH. The new company, which has just ... and the Max Planck Society (MPG), manufactures specialized mirrors ...
Cached Biology Technology:Nektar Therapeutics to Host Conference Call to Discuss Today's Announcement of a New Partnership for NKTR-118 and NKTR-119 2RURO Inc. Today Announced the Release of FreezerPro 2010, Frozen Sample Inventory and Information Management System 2Optics made to measure 2Optics made to measure 3
(Date:9/30/2014)... Munich report that a new class of chemical ... drugs. They have also pinpointed the relevant target ... agents. , Researchers led by LMU,s Professor ... Technische Universitt Mnchen have identified a class of ... the fight against malignant tumors. The compound is ...
(Date:9/30/2014)... Sept. 30, 2014  Spectra Automation, a ... the biotech and power generation industries, announced ... Bioprocess Manager, an easy-to-use and cost-effective data ... bioprocess development laboratories. Most ... and analyzer systems. Accessing and consolidating data ...
(Date:9/29/2014)... A species of gut bacteria called Clostridium ramosum , ... weight. The work is published this week in mBio ... Microbiology. , A research team from the German Institute ... human gut bacteria including C. ramosum gained weight ... C. ramosum were less obese even when consuming ...
Breaking Biology News(10 mins):Cancer therapy: Driving cancer cells to suicide 2Spectra Automation Introduces RECONN Bioprocess Manager 2Gut bacteria promote obesity in mice 2
... WASHINGTON, DC February 5, 2013 What do microbes have ... is yeast a microbe and every step in the ... freely-available report; FAQ: If the Yeast Ain,t Happy, Ain,t Nobody Happy: ... beer. "Every time someone brews a batch of beer, in ...
... with sexually transmitted infections aren,t getting the treatment they ... new Michigan State University study that highlights a wholly ... current medical guidelines. About half of the 735 ... at three hospitals in Grand Rapids, Mich. from 2008 ...
... The Federation of American Societies for Experimental Biology (FASEB) ... advocacy competition, Stand Up for Science. The competition solicited ... health, quality of life, or economy of local communities ... by ,Stand With Science, a group of graduate students ...
Cached Biology News:Yeast we can! New report answers questions on microbiology and beer 2Few pregnant women treated for sexually transmitted infections 2
... PAL label printer is portable, easy-to-use and makes ... Portable/Handheld Easy to use ... vial and slide sizes Time/Date stamp ... needs one Serialization feature makes you ...
... SPA Screening Assay, 5 x ... eliminate lengthy sample extraction procedures and ... 1.32-84.28 ng/ml (4-256 pmol/ml).Sensitivity: 0.65 ng/ml ... C. Category: Drug Screening & Cellular ...
The E. coli Expression System with Gateway Technology is designed to create E. coli expression clones containing the T7 promoter. The expression clones are ready for transformation and expression in ...
... C-1-tetrahydrofolate synthase, cytoplasmic ... Methylenetetrahydrofolate dehydrogenase (EC ... (EC 3.5.4.9); Formyltetrahydrofolate ... [Source:Uniprot/SWISSPROT;Acc:P11586] ...
Biology Products: